NEURONES: Organic growth up 5.7% in 1st quarter 2021
May 05 2021 - 11:40AM
NEURONES: Organic growth up 5.7% in 1st quarter 2021
PRESS INFORMATION Heading: 1st quarter 2021
revenues Nanterre,
May 5, 2021 (after trading)
Organic growth up 5.7% in
1st quarter 2021
(in € millions) |
Q1 2020 |
Q1 2021 |
growth |
of which organic |
Revenues |
135.3 |
144.2 |
+6.6% |
+5.7% |
Achievements
With organic growth up 5.7% in the first quarter
(compared with 5.4% for the same period last year), the group is
back on track with its pre-health crisis performance.
Operating profit (*) amounted to 10.4% of
revenues (compared with 9.3% in Q1 2020).
Compared to the 2020 Universal Registration
Document (www.neurones.net - Investors), the financial position has
not changed significantly.
Outlook
In the favorable context of:
- a significant proportion of
recurring managed services contracts,
- low exposure to affected
sectors,
- continued acceleration of digital
transformation,
NEURONES expects to achieve revenues of around
€560m in 2021, with an operating profit of around 9.5%.
(*) not audited and after inclusion of 0.3% of
expenses related to bonus shares.
About NEURONES
With 5,700 experts, and ranking among the
French leaders in management consulting and digital services,
NEURONES helps large companies and organizations implement their
digital projects, transform their IT infrastructures and adopt new
uses.
Euronext Paris (compartment B - NRO) - Enternext
Tech 40 - SRD (deferred settlement) mid-caps www.neurones.net
Press Relations:O'ConnectionValérie
HackenheimerTel.: +33 (0)6 12 80 35 20fmonnier@oconnection.fr |
NEURONESMatthieu VautierTel.:
+33 (0)1 41 37 41 37rp@neurones.net |
Investor Relations:NEURONESPaul-César BonnelTel.:
+33 (0)1 41 37 41 37investisseurs@neurones.net |
- neurones-first-quarter-2021-revenues
Neurones (EU:NRO)
Historical Stock Chart
From Nov 2024 to Dec 2024
Neurones (EU:NRO)
Historical Stock Chart
From Dec 2023 to Dec 2024